key: cord-0971540-dd8ov8fl
authors: Parigi, Tommaso Lorenzo; Bonifacio, Cristiana; Danese, Silvio
title: Is it Crohn’s disease?
date: 2020-05-01
journal: Gastroenterology
DOI: 10.1053/j.gastro.2020.04.066
sha: 92aed7a3ba9ceaf3571f058d36574431c586e5fe
doc_id: 971540
cord_uid: dd8ov8fl

nan

Question: An otherwise healthy 22 years old woman was admitted to a hospital for persistent diarrhea, abdominal cramps and weight loss over the previous weeks. Laboratory findings showed CRP 5.58 mg/dL (normal < 0.80 mg/dL), WBC 7350/μL, Hb 12.5 g/dL, calprotectin 22 μg/g (normal <50μg/g), remaining values were unremarkable. Stool cultures excluded common bacterial and protozoal pathogens, including Clostridium difficile. Abdominal ultrasound showed concentric thickening of the last ileal loop extending 7 cm proximal to the ileocecal valve.

A colonoscopy revealed an inflamed mucosa in the distal 15 cm of the ileum with edema and aphtous erosions, colonic examination was normal. Biopsies were taken in all tracts from distal ileum to the rectum and the histopathological examination was suggestive of active ileal Crohn's disease.

During hospitalization the patient was treated with a single course of oral steroids and received a 5 days course of levofloxacin 500mg once daily. She had a rapid clinical response and oral steroids were tapered within 8 weeks, after which she maintained clinical remission for 3 more months.

In March 2020, the patient was referred to the outpatients clinic of our center, complaining of worsening fatigue and recent onset of diarrhea, with 3-4 non-bloody bowel movements per day. Suspecting a Crohn's disease exacerbation a contrast enhanced intestinal magnetic resonance was performed. Radiologic examination showed regular distention of the intestine, no significant thickening of bowel walls, and no enhancement in the distal ileum ( Figure A) .

Other abdominal findings were normal, thus making a Crohn's flare improbable. Incidentally, on the cranial scans bilateral consolidations in peripheral pulmonary parenchyma were noticed in T2 sequences (white arrow in Figure B ) and T1 sequences after ev gadolinium infusion (white arrow in Figure C and Figure D) .

On the basis of the history, the clinical presentation and the radiologic findings, what is your diagnostic suspicion?

Answer: Finally, a nasopharyngeal swab tested positive for SARS-CoV-2. The patient did not meet the criteria for hospitalization nor treatment. She was therefore discharged at home, with indication to self-isolate, report to the hospital any change in symptoms or oxygen saturation, and wait two weeks before repeating a COVID-19 testing.

At two weeks follow-up she repeated two nasopharyngeal SARS-CoV-2 swabs that were both negative and she was thus declared virus-free. Diarrhea resolved spontaneously few days after the first COVID-19 test, along with an improvement of fatigue. At follow-up visit she reported feeling well and not experiencing gastrointestinal nor respiratory symptoms.

Gastrointestinal symptoms are common among patients with COVID-19 infection although their timing in the history of infection is yet to be clarified. In particular, diarrhea has been reported in up to 50.5% of patients alongside nausea and vomit which have been found in 1.0 -17.3%. 1 Like in the case described, these symptoms can be the main clinical manifestation of COVID-19 infection and, due to their non-specific nature, can mimic several gastrointestinal conditions. In a recent case series from Spain, COVID-19 presented in IBD patients with pneumonia and fever as most common symptoms, as well as diarrhea in 21%. 2 Hence, in the midst of COVID-19 outbreak, SARS-CoV-2 infection should be ruled out in the assessment of any IBD exacerbation.

In conclusion, we recommend considering COVID-19 in the differential diagnosis of any gastrointestinal condition presenting with diarrhea among its main manifestation. Generally, treatment of IBD, including biologics and JAK inhibitors, should not be suspended during COVID-19 pandemic as recently recommended by the International Organization for the Study of IBD (www.ioibd.org/ioibd-update-on-covid19-for-patients-with-crohns-diseaseand-ulcerative-colitis/). 3 Our described case was reported on SECURE IBD (Surveillance Epidemiology of Coronavirus Under Research Exclusion -IBD, https://covidibd.org/), an international registry aimed at monitor and report outcomes of confirmed COVID-19 occurring in IBD patients. We encourage all physicians caring for patients with IBD to contribute to it.

*CRP: C-reactive protein; WBC: white blood cells; Hb: hemoglobin

Diarrhea during COVID-19 infection: pathogenesis, epidemiology, prevention and management

Characteristics and prognosis of patients with inflammatory bowel disease during the SARS-CoV-2 pandemic in the Basque Country (Spain)

AGA Clinical Practice Update on Management of Inflammatory Bowel Disease During the COVID-19 Pandemic: Expert Commentary